Potential Benefits of ETI Therapy for Non-CF Bronchiectasis with CFTR Dysfunction
发布者：Unknown
·发布于: 2025-12-13
Discussion regarding how elexacaftor/tezacaftor/ivacaftor (ETI) therapy might benefit patients diagnosed with non-cystic fibrosis bronchiectasis who exhibit CFTR dysfunction.